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Abstract
The respiratory central pattern generator must respond to chemosensory cues to maintain oxygen 
(O2) and carbon dioxide (CO2) homeostasis in the blood and tissues. To do this, sensorial cells 
located in the periphery and central nervous system monitor the arterial partial pressure of O2 and 
CO2 and initiate respiratory and autonomic reflex adjustments in conditions of hypoxia and 
hypercapnia. In conditions of chronic intermittent hypoxia (CIH), repeated peripheral 
chemoreceptor input mediated by the nucleus of the solitary tract induces plastic changes in 
respiratory circuits that alter baseline respiratory and sympathetic motor outputs and result in 
chemoreflex sensitization, active expiration, and arterial hypertension. Herein, we explored the 
possibility that the CIH-induced neuroplasticity primarily consists of increased excitability of pre-
inspiratory/inspiratory neurons in the pre-Bötzinger complex. To evaluate this hypothesis and 
elucidate neural mechanisms for the emergence of active expiration and sympathetic overactivity 
in CIH-treated animals, we extended a previously developed computational model of the 
brainstem respiratory-sympathetic network to reproduce experimental data on peripheral and 
central chemoreflexes post-CIH. The model incorporated neuronal connections between the 2nd-
order NTS neurons and peripheral chemoreceptors afferents, the respiratory pattern generator, and 
sympathetic neurons in the rostral ventrolateral medulla in order to capture key features of 
sympathetic and respiratory responses to peripheral chemoreflex stimulation. Our model identifies 
the potential neuronal groups recruited during peripheral chemoreflex stimulation that may be 
required for the development of inspiratory, expiratory and sympathetic reflex responses. 
Moreover, our model predicts that pre-inspiratory neurons in the pre-Bötzinger complex 
experience plasticity of channel expression due to excessive excitation during peripheral 
chemoreflex. Simulations also show that, due to positive interactions between pre-inspiratory 
neurons in the pre-Bötzinger complex and expiratory neurons in the retrotrapezoid nucleus, 
increased excitability of the former may lead to the emergence of the active expiratory pattern at 
normal CO2 levels found after CIH exposure. We conclude that neuronal type specific 
neuroplasticity in the pre-Bötzinger complex induced by repetitive episodes of peripheral 
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chemoreceptor activation by hypoxia may contribute to the development of sympathetic over-
activity and hypertension.
Keywords
respiration; obstructive sleep apnea; hypertension; chronic intermittent hypoxia; peripheral 
chemoreception; plasticity
Introduction
Hypertension is a highly prevalent public health problem that affects a large proportion of 
population worldwide (Kearney et al., 2005, Carey, 2013, Go et al., 2014). Accumulating 
evidence shows that the reducing sympathetic nerve activity decreases blood pressure in 
hypertensive patients, especially in those who are resistant to pharmacologic 
antihypertensive treatment (Esler, 2009, Fisher and Paton, 2012), suggesting that 
sympathetic overactivity is a major contributor to the development and maintenance of 
hypertension. Moreover, experimental data indicate that increased activity of the 
sympathetic nervous system is pivotal for the development of high blood pressure in rodent 
models of hypertension (Simms et al., 2009, Malpas, 2010, Briant et al., 2015). This 
scenario of hypertension and sympathetic overactivity is observed in obstructive sleep apnea 
(OSA) patients (Narkiewicz et al., 1998). OSA is a condition characterized by recurrent 
upper airway collapses during sleep and affects approximately 20% of adult population in 
USA (Konecny and Somers, 2011). Untreated OSA has cumulative effects on the 
cardiovascular system, leading to augmented baseline sympathetic activity and arterial 
hypertension that can be refractory to pharmacologic therapies (Williams et al., 2010, 
Pedrosa et al., 2011). Studies estimate that 50–56% of individuals with OSA are 
hypertensive (Dudenbostel and Calhoun, 2011).
Clinical and experimental evidence suggests that chronic exposure to the intermittent 
hypoxia (CIH) is a main factor leading to cardiovascular dysfunction in OSA patients 
(Fletcher, 2001, Caples et al., 2005). In rats, CIH promotes hypertension linked to elevated 
baseline sympathetic vasomotor tone and higher noradrenaline plasma levels (Braga et al., 
2006, Zoccal et al., 2007, Zoccal et al., 2008, Zoccal et al., 2009) highlighting a relationship 
among CIH, sympathetic overactivity and hypertension. Importantly, the high levels of 
sympathetic activity of CIH rats were markedly associated with a strengthened coupling 
between respiratory and sympathetic networks. Indeed, we originally reported (Zoccal et al., 
2008) that CIH exposure promotes an increase in sympathetic activity during the expiratory 
phase, specifically during the late part of expiration (late-E). These additional expiratory 
bursts in sympathetic activity of CIH rats were coupled to the late-E bursts emerging in 
abdominal expiratory motor output. Moreover, the late-E activity was present at rest in 
eucapnia in CIH-treated animals but never in untreated controls, and was eliminated by a 
reduction of CO2 content in the perfusate (Molkov et al., 2011). The involvement of 
respiratory-sympathetic interactions in the development of hypertension in CIH rats is 
further supported by recent findings that late-E modulation in the pre-sympathetic neurons 
of rostral ventrolateral medulla (RVLM ) depends on synaptic inputs from bulbar respiratory 
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neurons rather than on changes in their intrinsic properties (Moraes et al., 2013, Moraes et 
al., 2014). All together these data indicate that CIH-induced sympathetic overactivity is 
linked to the transition of expiration from a passive to an active process at rest. These 
findings represent novel and unexplored aspects of central mechanisms underpinning arterial 
hypertension in CIH rats (Moraes et al., 2012b).
The development of arterial hypertension in rats exposed to CIH is fully prevented by 
previous ablation of carotid body peripheral chemoreceptors (Fletcher et al., 1992), 
indicating that the plasticity in the neural circuitries of the peripheral chemoreflex, elicited 
by repeated stimulation during CIH (Moraes et al., 2015), may underpin the development of 
the observed respiratory and sympathetic changes. Therefore, it is important to understand 
the neural pathways engaged during peripheral chemoreceptor stimulation in order to 
identify potential neural mechanisms triggering active expiration and sympathetic 
overactivity in CIH rats. Accordingly, the objectives of this study were (i) to model the 
neural pathways required for the adjustments in the respiratory and sympathetic motor 
outputs during the peripheral chemoreflex activation, (ii) to understand the functional 
implications of their repetitive activation during CIH conditioning, and (iii) to shed light on 
where within the network the origin of neuronal plasticity occurs that is responsible for the 
sustained active expiration and sympathoactivation following CIH exposure.
Methods
In the present study, we combined recent published studies (Braga et al., 2006, Zoccal et al., 
2008, Molkov et al., 2011, Moraes et al., 2012a, McBryde et al., 2013, Moraes et al., 2014) 
and new experimental data obtained in the in situ arterially perfused preparation of 
decerebrate rats, as described in details below.
Experimental data
Animals and ethical approval—Experiments were performed on male Holtzman rats, 
weighing 70–90 g, obtained from the Animal Care Unit of the São Paulo State University, 
Araraquara, and kept at 22±1 °C on a 12-h light/dark cycle (lights on 06:00 – lights off 
18:00), with access to food and water ad libitum. All experimental approaches followed the 
Guide for the Care and Use of Laboratory Animals published by the US National Institutes 
of Health (NIH publication No. 85-23 revised 1996) and by the Brazilian National Council 
for Animal Experimentation Control (CONCEA), and was approved by the Local Ethical 
Committee in Animal Experimentation (protocol 18/2014).
Chronic intermittent hypoxia (CIH)—The rats were exposed to CIH as previously 
described (Zoccal et al., 2008). Briefly, the animals were housed in collective cages 
(maximum of 5 animals per cage) and maintained inside chambers equipped with gas 
injectors as well as sensors of O2, CO2, humidity and temperature, at controlled conditions 
of temperature (22±1°C) and humidity (55±10%). The CIH protocol consisted of 5 minutes 
of normoxia (FiO2 of 20.8%) followed by 4 minutes of pure N2 injection into the chamber in 
order to reduce the fraction of inspired O2 (FiO2) to 6%, remaining at this level for 40 
seconds. After this hypoxic period, pure O2 was injected to return the FiO2 back to 20.8%. 
This 9-minute cycle was repeated 8 hours a day (from 9:30 am to 5:30 pm) for 10 days. 
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During the remaining 16 hours, the animals were maintained at a FiO2 of 20.8%. The 
injections of N2 and O2 (White Martins, São Carlos, Brazil) were regulated by a solenoid 
valve system whose opening-closing control was performed by a computerized system 
(Oxycycler, Biospherix, USA). In an identical chamber in the same room, the control group 
was exposed to a FiO2 of 20.8% 24 hours a day for 10 days. The control rats were also 
exposed to a similar valve noise due to the frequent injection of O2 to maintain the FiO2 at 
20.8%. In both CIH and control chambers, the gas injections were performed at the upper 
level of the chamber in order to avoid direct jets of gas impacting on the animals, which 
could cause stress.
In situ arterially perfused preparation of decerebrate rats—Arterially perfused 
preparations (Paton, 1996) of control and CIH rats were surgically prepared, as previously 
described (Zoccal et al., 2008). The rats were deeply anesthetized with halothane 
(AstraZeneca, Cotia, SP, Brazil) until loss of paw withdrawal reflex, transected caudal to the 
diaphragm, submerged in a chilled Ringer solution (in mM: NaCl, 125; NaHCO3, 24; KCl, 
3; CaCl2, 2.5; MgSO4, 1.25; KH2PO4, 1.25; dextrose, 10) and decerebrated at the 
precollicular level. Lungs were removed. Preparations were then transferred to a recording 
chamber, the descending aorta was cannulated and perfused retrogradely with Ringer 
solution containing 1.25 % Polyethylene glycol (an oncotic agent, Sigma, St Louis, USA) 
and a neuromuscular blocker (vecuronium bromide, 3–4 µg.mL−1, Cristália Produtos 
Químicos Farmacêuticos Ltda., São Paulo, Brazil), using a roller pump (Watson-Marlow 
502s, Falmouth, Cornwall, UK) via a double-lumen cannula. The perfusion pressure was 
maintained in the range of 50–70 mmHg by adjusting the flow rate to 21– 25 ml.min−1 and 
by adding vasopressin to the perfusate (0.6 – 1.2 nM, Sigma, St. Louis, MO, USA). The 
perfusate was gassed continuously with 5% CO2-95% O2, warmed to 31–32°C and filtered 
using a nylon mesh (pore size: 25 µm, Millipore, Billirica, MA, USA). Sympathetic and 
respiratory nerves were isolated and their activity recorded simultaneously using bipolar 
glass suction electrodes held in micromanipulators (Narishige, Tokyo, Japan). Left phrenic 
nerve (PN) discharges were recorded from its central end and its rhythmic ramping activity 
was used to monitor preparation viability. Left cervical vagus (cVN) and hypoglossal nerves 
(HN) as well as right thoracic/lumbar abdominal nerves (AbN; T13-L1) were isolated, cut 
distally and their central activity recorded. Thoracic sympathetic activity was recorded from 
the left sympathetic chain (tSN) at T8–T12 level. All the signals were amplified, band-pass 
filtered (0.1–3 kHz; P511, Grass Technologies, Middleton, USA) and acquired in an A/D 
converter (CED micro 1401, Cambridge Electronic Design, CED, Cambridge, UK) to a 
computer using Spike 2 software (5 KHz, CED, Cambridge, UK). At the end of the 
experiments, the perfusion pump was turned off to determine the electrical noise (after the 
death of the preparations).
All analyses were carried out on rectified and integrated signals (time constant of 50 ms) and 
performed off-line using Spike 2 software (CED, Cambridge, UK) after noise subtraction. 
PN burst frequency was determined from the time interval between consecutive integrated 
phrenic peak bursts and expressed in bursts per minute (bpm). tSN activity was measured as 
the mean values (in µV) of integrated signals. The changes in the PN burst frequency and 
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tSN in response to peripheral chemoreflex activation were expressed as percentage values in 
relation to basal values prior to the stimulus.
Peripheral chemoreflex activation—Peripheral chemoreceptors were stimulated in the 
in situ preparations by injections of potassium cyanide (KCN 0.05%, 50 µl) into the 
descending aorta via the perfusion cannula as previously described (Costa-Silva et al., 2010). 
The stimulation of the peripheral chemoreflex receptors by KCN produced consistent 
autonomic and respiratory responses, which present low variability within and among the 
experiments.
Statistical analyses—The data were expressed as mean ± standard error of mean (SEM). 
Before analysis, data normal distribution was tested using the Shapiro–Wilk normality test. 
The sympathoexcitatory and tachypneic responses to peripheral chemoreceptor activation in 
control and CIH rats were compared using, unpaired Student’s t-test or two-way ANOVA for 
repeated measurements followed by Newman-Keuls post-test, respectively. The analysis was 
carried out using GraphPad Prism software (version 5, La Jolla, CA, USA) and differences 
were considered significant at P < 0.05.
Modeling and simulations
The model presented here is based on a previous model of central chemoreceptor 
sensitization from (Molkov et al., 2011, Molkov et al., 2014b), which in turn combined a 
model describing the origin of abdominal late-E activity (Molkov et al., 2010) and a model 
describing sympathy-respiratory coupling in the context of the baroreflex (Baekey et al., 
2010). All of these models descend from the model described by Rybak et al. (2007) and 
Smith et al. (2007), which explains the change in respiratory patterns due to successive 
pontine and medullary transections performed in rats. Most neuronal populations were 
composed of single-compartment Hodgkin-Huxley style neuronal models. Each population 
contained 20 or 50 neurons. Neurons in postsynaptic populations each received input from 
every neuron in the presynaptic population or the appropriate drive element. The output of 
certain populations, including motoneurons, was obtained by integrating excitatory synaptic 
input. Heterogeneity of model parameters and initial conditions (such as membrane 
potential, calcium concentration, and gating variables) were set by random distributions. 
Parameters for synaptic weights including changes relative to Molkov et al. (2011) can be 
found in Table 1.
Simulations were performed using the NSM simulation package version 3.0 developed at 
Drexel University by S. Markin, I. Rybak, and N. Shevtsova and ported for parallel 
computing on high-performance clusters using OpenMPI by Y. Molkov. Numerical solutions 
to ordinary differential equations were computed using the exponential Euler method for 
integration with a step of 0.1 ms.
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Results
Peripheral chemoreflex, respiratory and sympathetic adjustments and exposure to chronic 
intermittent hypoxia: experimental evidence
Effects of CIH on CO2 threshold for apnea and active expiration in rats in situ
—We previously demonstrated (Molkov et al., 2011) that rats exposed to chronic 
intermittent hypoxia exhibit changes in excitability within the respiratory network. This was 
verified by the evaluation of the respiratory responses to varying levels of CO2. Figure 1 
shows the AbN and PN motor patterns in in situ preparations of control rats (upper traces) 
and in rats after CIH conditioning (lower traces) at different CO2 contents in the perfusate: 
normocapnia (5% CO2, middle traces); hypercapnia (7% and 10% CO2, right traces) and 
hypocapnia (1% and 3% CO2, left traces). As it is evident from the figure, in normocapnia 
control rats exhibit a passive expiratory pattern, as only PN activity shows rhythmic 
discharges of inspiratory activity, and AbN remains fairly quiescent. With progressive 
increase in CO2 large amplitude discharges appear in the AbN activity of control rats at the 
late-E phase of the respiratory cycle signifying a transition to active expiration. In CIH-
conditioned rats, AbN late-E discharges are present during normocapnia. Lowering CO2 
content to 3% can abolish these discharges. So, the CO2 threshold for transition to active 
expiration is between 5% and 7% for naïve animals, and between 3% and 5% for the CIH 
conditioned rats.
As CO2 level is decreased from 3% to 1% the PN rhythmic activity stops in naïve animals 
but not in rats exposed to CIH (see first column of traces in Fig. 1). These results imply that 
the CO2 apneic threshold is between 1% and 3% CO2 in the control group, and below 1% in 
the CIH animals. Accordingly, both thresholds for apnea and for the transition to active 
expiration are, by approximately 2% CO2, lower in CIH conditioned animals as compared to 
naïve ones.
Respiratory and sympathetic adjustments elicited by peripheral chemoreflex 
activation—Previous studies have demonstrated the changes in the pattern of PN, tSN and 
AbN activities in response peripheral chemoreflex activation (Dick et al., 2004, Moraes et 
al., 2012a). Herein, we extended this characterization and also evaluated the changes in cVN 
and HN activities. Transient stimulation of CB peripheral chemoreceptors of control in situ 
preparations with KCN has a profound effect on activity patterns in all motor outputs which 
lasts 10–15s (see Fig. 2 for a typical response). There is an approximately two-fold increase 
in respiratory frequency accompanied by individual changes in patterns. The post-
inspiratory component in the cVN pattern is exaggerated in amplitude, and has a square 
rather than decrementing pattern typical for the baseline activity. Post-I discharges also 
appear in the abdominal, hypoglossal and sympathetic nerves. Importantly, at the end of the 
stimulus these strong post-I discharges disappear from all nerves simultaneously suggesting 
that they may have a common origin. In addition, the AbN exhibits late-E discharges during 
stimulation which strongly resembles hypercapnia-evoked late-E activity. Similar late-E 
discharges are also seen in the sympathetic outflow.
It was previously suggested that the source of late-E AbN activity activated by hypercapnia 
was in the RTN/pFRG (Janczewski and Feldman, 2006, Abdala et al., 2009, Molkov et al., 
Barnett et al. Page 6
Exp Neurol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2010). To understand if the AbN modulation induced by peripheral chemoreflex originates 
from the same location, Moraes et al. (2012a) suppressed the RTN activity by muscimol 
(GABAA receptor agonist) before stimulating peripheral chemoreceptors by KCN. 
Interestingly, late-E discharges disappeared from both abdominal and sympathetic nerves 
without affecting the post-I responses. This observation suggests that post-I and late-E 
activities in AbN and tSN during peripheral chemoreflex have different origins. Late-E 
activity most probably has the same source as observed during hypercapnia originating from 
the RTN, whereas the source of post-I activity is located elsewhere.
Exaggerated respiratory and sympathetic chemoreflex responses after CIH 
exposure—Typical recordings of PN, AbN and tSN activities of control and CIH rats, 
illustrating the pattern of changes in response to peripheral chemoreflex activation, are 
shown in Fig. 3. Consistent with previous observations (Braga et al., 2006), we verified that 
in situ preparations of CIH rats (n=8) exhibit amplified sympathoexcitatory responses to 
peripheral chemoreflex stimulation (128±8 vs 94±5%, P < 0.05) in comparison to the 
control group (n=7). The enhanced sympathetic chemoreflex response in CIH rats also 
exhibit a respiratory modulation, with burst preferentially during post-inspiratory phase. In 
relation to the PN frequency, the analysis of percentage changes respective to basal values 
show that CIH and control groups present a similar magnitude of increase in PN frequency 
(114±18 vs 80±21%, 2s after stimulation). However, the PN frequency remains elevated at 4 
(144±36 vs 80±21%, P < 0.01) and 6s (151±36 vs 66±13%, P < 0.001) after the stimulation 
of peripheral chemoreceptors in CIH rats, indicating prolongation of tachypnea. With respect 
to AbN chemoreflex response, the magnitude of increase is similar in both groups (104±21 
vs 105±34%). However, a different pattern of AbN response is observed in CIH in relation 
to control rats. In control rats, the relative increase in AbN expiratory activity occurs during 
the post-inspiration (55±2% of the response) and late expiration (45±2% of the response), 
with a prevalence in the former (P<0.05). In the CIH group the evoked AbN response is 
shifted towards the late expiratory phase (late expiration: 65±2% vs post-inspiration: 
35±2%, P < 0.001), indicating a preferential increase of late expiratory AbN evoked activity 
during peripheral chemoreflex activation. Together, these data supports the notion that the 
processing of sympathetic and inspiratory and late-expiratory responses to peripheral 
chemoreflex is facilitated in rats exposed to CIH.
Pre-I/I neurons in spontaneously hypertensive rats—In a different animal model of 
neurogenic hypertension, the spontaneously hypertensive rat (SHR), Moraes et al. (2014) 
demonstrated that intrinsically bursting neurons in the pre-BötC were found to have altered 
electrophysiological properties. Specifically, the authors showed that pre-BötC pre-
inspiratory neurons are more excitable due to significantly lower conductance of the leak 
current. Interestingly, SHR and CIH rat models of hypertension share many common 
features: 1) in both models, strengthened respiratory-sympathetic coupling are suggested to 
be involved in the development/maintenance of arterial hypertension (Zoccal et al., 2008, 
Moraes et al., 2014); 2) the carotid body chemoreceptors play a pivotal role for the 
development of hypertension in both models (Fletcher et al., 1992, Abdala et al., 2012); 3) 
the sympathetic response to peripheral chemoreceptors are amplified in SHR and CIH rats 
(Braga et al., 2006, Simms et al., 2009, Tan et al., 2010, Moraes et al., 2014), suggesting a 
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sensitization of processing of peripheral chemoreceptor inputs; 4) SHR also exhibit a late-
expiratory component in the AbN, in the cervical sympathetic and in the pre-sympathetic 
RVLM neuronal activity at normal (5%) CO2 levels strongly resembling respiratory pattern 
of control (Wistar) animals at 7% CO2 (Zoccal et al., 2008, Moraes et al., 2013, Moraes et 
al., 2014); and 5) SH animals also have a lower apneic threshold compared to Wistar rats 
(Moraes et al., 2014) similar to CIH vs. control (Molkov et al., 2011). Based on these 
similarities, we hypothesize that CIH-conditioned animals have altered baseline respiratory 
patterns due to increased excitability of pre-I/I population in pre-BötC because of the 
reduced leak conductance of these neurons (Moraes et al., 2014, 2015). We further test this 
hypothesis using computational modeling.
Effects of peripheral chemoreceptor activation on the brainstem respiratory and 
sympathetic networks: insights from computational modeling
Model description—The main objective of the modeling part of our study was to provide 
mechanistic interpretation of the processes involved in peripheral chemoreflex modulation of 
the respiratory and pre-sympathetic networks. This included: (1) an increase in respiratory 
frequency; (2) the appearance of post-I activity in the HN, AbN, and tSN and an 
augmentation of post-I activity amplitude in the cVN; (3) the appearance of late-E activity in 
the HN, AbN, and tSN; and (4) an increase in respiratory-independent activity of tSN.
The model was developed as an extension of previous models (Baekey et al., 2010, Molkov 
et al., 2011, Rybak et al., 2012, Molkov et al., 2014b) to include a population of 2nd-order 
cells in the NTS receiving peripheral chemoreceptor inputs and their efferent projection to 
ventromedullary compartments. The schematic of the extended model is shown in Fig. 4. It 
replicates the four effects of peripheral chemoreceptor activation on respiratory and 
sympathetic outflows described above.
We extended the model to include new neuronal populations that mediate the peripheral 
chemoreflex. During peripheral chemoreflex, input from the carotid body (CB) was 
represented by a constant drive to the 2nd-order peripheral chemoreceptors in the NTS. This 
population of simple spiking neurons distributed excitatory projections to the respiratory and 
sympathetic circuits. To account for the increase in respiratory frequency, which should 
primarily occur through shortening of the E2 phase, we implemented direct excitation from 
the 2nd-order NTS neurons mediating the chemoreflex to the early-I (1) and pre-I/I 
populations of the pre-BötC. The pre-I/I population is the primary excitatory population 
contributing to the initiation of inspiration.
To account for the post-I activity in motoneuron output, we introduced a post-I population 
(bulbo-spinal cVRG). This population receives tonic excitation from the 2nd-order NTS 
neurons during peripheral chemoreflex. In addition, the activity of this population is 
modulated by the respiratory CPG; inhibition from aug-E and early-I (2) shape its output to 
allow only post-inspiratory activity. This population receives tonic excitation from 2nd-order 
chemoreceptive neurons in the NTS. Activation of this population during inspiration is 
prevented by inhibition from early-I (2); activation of this population during E2 is 
suppressed by inhibition from aug-E. Thus, activation of and excitation from the 2nd-order 
chemoreceptive NTS neurons translate to post-I activity in the cVRG. This post-I (cVRG) 
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population is responsible for post-I activity in the HN, AbN, and tSN and augments post-I 
component in the cVN.
In our previous model, we described how CO2-sensitive drive from the RTN mediated the 
central chemoreflex in respiratory circuits (Molkov et al., 2010, Molkov et al., 2011). 
Increased drive from the RTN could drive the pFRG late-E population to threshold, and in 
this way, the central chemoreflex induced the onset of bursting activity in the pFRG, 
observed as late-E activity in the AbN. In the extended model, a CO2-sensitive drive excites 
two distinct neuronal populations in the RTN (RTN-late-E and RTN-cpg) (see Fig. 4). One 
of these populations—the RTN-cpg—also received input from 2nd-order NTS 
chemoreceptive neurons. The dynamics of individual neurons in these two RTN populations 
were not modeled; rather, we directly simulated the firing rate of the population. The RTN-
cpg population projected to: pre-I/I (pre-BötC), early-I (1) (pre-BötC), post-I (BötC), and 
late-E (pFRG). The RTN-late-E population only projected to the late-E population of the 
pFRG. Therefore, the pFRG late-E population receives excitatory projections from both 
peripheral chemoreflex sensitive and peripheral chemoreflex insensitive central 
chemoreceptive populations in the RTN. The CO2-dependence of RTN-cpg and RTN-late-E 
is the same and mediates the central chemoreflex in a similar fashion to the direct CO2-
sensitive drive in Molkov et al. (2011). Progressive hypercapnia and hypocapnia were 
modeled by changing the magnitude of the CO2 sensitive drive to RTN-cpg and RTN-late-E.
Since stimulation of the peripheral chemoreceptors can initiate late-E activity in the AbN 
which is RTN-dependent (Moraes et al., 2012a), we extended the model to include excitation 
from 2nd-order NTS peripheral chemoreceptive neurons to augment excitatory drive from 
the RTN to the CPG. We implemented a direct projection from the 2nd-order NTS 
chemoreceptive neurons to the RTN-cpg population. The RTN-cpg population distributes 
both central and peripheral chemosensory drive to the respiratory circuits. Notice that the 
RTN-late-E population does not receive excitation from the 2nd-order NTS chemoreceptive 
neurons, so this component of excitatory input to the pFRG late-E population is dependent 
on the central chemoreflex but independent of the peripheral chemoreflex.
The model by Baekey et al. (2010) described the baroreflex circuits, including 2nd-order 
baroreceptive NTS neurons and the pre-sympathetic circuits in the ventrolateral medulla. In 
that model, 2nd-order baroreceptive NTS neurons directly excited the CVLM, which 
inhibited RVLM to provide sympathoinhibition. Here, we implement a parallel pathway 
where 2nd-order peripheral chemoreceptive NTS neurons project directly to the RVLM in 
order to mediate sympathoexcitation during peripheral chemoreflex for which there is 
experimental evidence (Aicher et al., 1996, Koshiya and Guyenet, 1996).
As mentioned above, hypercapnia induces late-E activity in the AbN. CIH rats experience a 
hypocapnic shift in the threshold for emergence of this late-E activity (Abdala et al., 2009, 
Molkov et al., 2010, Molkov et al., 2011) (Fig. 1). On the other hand, experimental evidence 
in SHR suggests that the pre-I/I population in the pre-BötC becomes more excitable via a 
decrease in leak conductance (Moraes et al., 2014). We use this evidence to formulate the 
hypothesis that repetitive activation of peripheral and, hence, central chemoreceptors during 
CIH conditioning induces plasticity in this population as recently proposed (Moraes et al., 
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2015, Zoccal, 2015); specifically, we model the respiratory plasticity evoked by CIH as a 
decrease in the leak conductance of the pre-I/I population. The average leak conductance of 
these neurons was decreased from 2.9 nS in the control model to 2.3 nS in the CIH model. In 
order for the increase in excitability of the pre-I/I population to contribute to the excitability 
of the late-E (pFRG) population, we implemented a direct excitatory projection from pre-I/I 
(pre-BötC) to late-E (pFRG). The relative increase of the sympathoexcitatory response to 
peripheral chemoreceptor activation was implemented by a change in the chemosensory 
drive to 2nd-order peripheral chemoreceptive NTS neurons (see Table 1).
Simulation of peripheral chemoreceptor activation in naïve rats—The extended 
model was used to investigate the effects of peripheral chemoreceptors activation on the 
respiratory-sympathetic networks. Fig. 5A and Fig. 6A depict the activity of the respiratory 
circuits during normal conditions and during activation of peripheral chemoreceptors. A 
square pulse of excitatory drive to the 2nd-order NTS chemoreceptive neurons elicited an 
increase in network frequency and a change in the pattern of motoneuron output. Upon 
peripheral chemoreceptor activation, additional excitation to pre-I/I and early-I (1) neurons 
let them more easily overcome inhibition from the inhibitory populations in the BötC and 
initiate inspiration. Hence, the expiratory phase decreased in duration. Specifically, the 
duration of bursts in the aug-E and post-I populations of the BötC decreased (Fig. 6A). 
However, the duration of inspiration (Fig. 5A) and the burst duration of early-I (1) (Fig. 6A) 
did not substantially change. After chemoreceptor stimulation, the model captured the 
appearance of post-I activity in the HN, AbN, and tSN and increased post-I activity in the 
cVN that are prevalent in experimental recordings (Fig. 7). In the model, this activity was 
driven by the post-I (cVRG) population; it was silent without input from 2nd-order NTS 
chemoreceptive neurons, and received respiratory modulation in the form of inhibition from 
BötC aug-E and strong inhibition from pre-BötC early-I (1) (see Fig. 4). This inhibition 
occurred in the I-phase and E2-phase of respiration (Fig. 6A).
We propose that 2nd-order NTS chemoreceptive neurons project directly to central 
chemosensory populations of the RTN. During peripheral chemoreceptor activation, the CO2 
sensitive drive from RTN-cpg to the respiratory circuits is augmented. Hence, the pathway 
for stimulation of the late-E (pFRG) population becomes active (Fig. 6A). The model 
captured the appearance of late-E activity in the HN, AbN, and tSN that is prevalent in 
experimental recordings. The increase in drive to the pFRG was sufficient to induce periodic 
bursts of activity immediately preceding each inspiratory burst (Fig. 7). Tonic and 
respiratory-modulated activity in tSN during peripheral chemoreceptor activation increased 
due to converging direct and indirect excitatory pathways to RVLM. RVLM possessed a 
strong post-I component due to excitation from the post-I population in cVRG and a late-E 
component originating from the pFRG (Fig. 7).
Simulation of transient activation of peripheral chemoreceptors in naïve rats 
with RTN suppressed—Evidence suggests that late-E activity in the AbN during 
hypercapnia is dependent on an excitatory drive from the RTN (Molkov et al., 2010, Moraes 
et al., 2012a). Moreover, late-E activity in the AbN is abolished upon suppression of the 
RTN (Moraes et al., 2012a). Here, we reproduce experimental results of RTN suppression in 
Barnett et al. Page 10
Exp Neurol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the model. Fig. 5B and Fig. 6B depict activation of peripheral chemoreceptors with the RTN 
suppressed. To simulate the effects of muscimol injected in the RTN, we inhibited the 
central chemosensory populations in the RTN and the late-E pacemaker in pFRG. This 
manipulation was mimicked by reducing the CO2 sensitive drive to RTN-cpg and RTN-late-
E from 1.08 nS to 0.84 nS. Input from 2nd-order NTS peripheral chemoreceptive neurons to 
the central chemosensory complex in the RTN was not able to overcome inhibition by 
muscimol and activate the late-E population. The activation of the post-I population in the 
cVRG and the projections from the 2nd-order NTS chemoreceptive neurons into the 
respiratory CPG and pre-sympathetic groups was unaffected by suppression of the RTN 
(Fig. 5B and Fig. 6B). Due to the inhibition of the RTN, the late-E population in the pFRG 
remained silent during peripheral chemoreceptor activation (Fig. 6B), and hence, no late-E 
activity appeared in the AbN and tSN motor outputs (Fig. 5B). Decrease in drive to the RTN 
also reduces drive distributed to the CPG; RTN suppression induces a reduction in the 
baseline frequency of the respiratory rhythm.
Simulation of transient activation of peripheral chemoreceptors in CIH rats—
The main difference in the effect of peripheral chemoreceptors in CIH compared to naïve 
rats is a substantial increase in sympatho-excitation (Braga et al., 2006) (Fig. 3). The tonic 
component of sympatho-excitation is mediated by a direct projection from 2nd-order NTS 
chemoreceptive neurons to the pre-sympathetic RVLM. Activation of this chemosensory 
drive leads to a tonic component to the sympathetic outflow during peripheral 
chemoreceptor activation by means of this direct projection to RVLM (Fig. 8A). To 
accommodate an increase in sympatho-excitation in CIH compared to the control model, we 
increased the amplitude of the peripheral chemoreceptor input by a factor of approximately 
2. During peripheral chemoreceptor activation, the firing frequency of 2nd-order NTS 
chemoreceptive neurons is greater in the CIH model than in the control model. As such, the 
efficacy of the excitatory projection to RVLM is greater, which causes greater sympathetic 
outflow in the CIH model upon activation of the peripheral chemoreceptors (Fig. 8B). These 
effects of increased chemosensory drive in the CIH model are only visible during activation 
of the peripheral chemosensors.
Simulation of progressive hypercapnia and hypocapnia in the naïve model 
and the CIH model—A hallmark of CIH in the respiratory circuits is a hypocapnic shift in 
the threshold for the emergence of self-sustained rhythmic respiratory activity (apneic 
threshold) and a hypocapnic shift in the threshold for the emergence of active expiration. 
Previously, we described these changes in terms of direct sensitization of the RTN to the 
partial pressure of CO2 in the blood (Molkov et al., 2011, Rybak et al., 2012, Molkov et al., 
2014b). The previous model does not describe the mechanism by which CIH induces 
plasticity in the respiratory CPG. As described above, the pre-I/I population in the pre-BötC 
of SHR has smaller leak conductance compared to Wistar rats (Moraes et al., 2014). Here, 
we extend the model to incorporate similar change in the pre-I/I population to explain CIH 
induced plasticity to the respiratory CPG. Increased excitability of pre-I/I population readily 
explains a lower apneic threshold after CIH. By adding a glutamatergic excitatory projection 
from this pre-I/I population to the late-E population in the pFRG, the increased excitability 
in the pre-BötC is integrated by the pFRG to lower its threshold for activation. This 
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projection mediates a change in the active expiration threshold induced by plasticity to the 
pre-I/I population in the CIH model.
In the model, we incrementally increased central chemosensory drive in the control and CIH 
models to simulate progressive increase in blood CO2 from normocapnia at 5% to mild and 
then strong hypercapnia at respectively 7% and 10% partial pressure of CO2 (Fig. 9A). To 
accommodate progressive hypercapnia in the model, we changed the weight of the CO2 
sensitive drive to RTN-cpg and RTN-late-E to 1.2 nS for 7% CO2 and to 1.32 nS for 10% 
CO2. This simulation is parallel to experiments performed in the arterially perfused 
preparation where the partial pressure of CO2 in the perfusate was implemented over the 
same incremental range (Molkov et al., 2011) (Fig. 1). In the control model, active 
expiration (marked by the presence of late-E activity in the AbN) emerges at 7% CO2 (Fig. 
9A). The frequency of these late-E AbN bursts increased in a quantal fashion (Molkov et al., 
2010, Rubin et al., 2011) from 1:2 AbN bursts per inspiratory PN bursts at 7% CO2 to 1:1 
AbN bursts per inspiratory PN bursts at 10% CO2. In the CIH model, the threshold for 
emergence of late-E AbN activity is decreased (Fig. 9A) as in normocapnia (5% partial 
pressure of CO2), AbN bursts are already present after CIH conditioning.
We incrementally decreased central chemosensory drive in the control and CIH models to 
simulate a progressive decrease in blood CO2 partial pressure from normocapnia at 5% 
blood CO2 to mild and then strong hypocapnia - 3% and 1% partial pressure of CO2 
respectively. We accomplished progressive hypocapnia in the model by decreasing the 
weight of the CO2 sensitive drive to RTN-cpg and RTN-late-E to 0.72 nS for 3% CO2 and to 
0 nS for 1% CO2. In the control model, respiratory activity— represented as inspiratory 
bursts reflected in the PN—persists in mild hypocapnia (Fig. 9B, Control, 3% CO2) but 
disappears in strong hypocapnia (Fig. 9B, Control, 1% CO2). After CIH a decrease from 5% 
to 3% CO2 eliminates late-E discharges in AbN (Fig. 9B, After CIH). A further decrease to 
1% CO2 does not stop the respiratory rhythm as opposed to the control case.
Discussion
The model presented qualitatively reproduces the effects of peripheral chemoreflex 
activation in the arterially perfused preparation of decerebrate rats. By changing a subset of 
biophysical parameters, the model is also able to reproduce the response to progressive 
hypercapnia and hypocapnia as well as increased sympathoexcitation in CIH. This model 
provides possible mechanistic explanations to the peripheral chemoreflex response and to 
plasticity induced by CIH. The model is based on several hypotheses that can be tested in 
experimental animals (each developed further below): (Hypothesis 1) 2nd-order peripheral 
chemoreceptive neurons in the NTS functionally project directly to the RTN central 
chemoreceptors (the anatomical projections were previously confirmed by Takakura et al. 
(2006)); (Hypothesis 2) sympathetic neurons in the RVLM receive convergent excitatory 
inputs from late-E (pFRG), a post-I population in the cVRG, and 2nd-order chemoreceptive 
neurons in the NTS; and (Hypothesis 3) CIH-induced plasticity in the brainstem circuits can 
be explained be a down-regulation of ohmic leak channels in the pre-I/I population (pre-
BötC).
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Peripheral chemoreflex in control rats
During peripheral chemoreceptor stimulation the respiratory frequency substantially 
increases (Fig. 2) whereas RTN central chemoreceptor activation during hypercapnia does 
not lead to significant frequency variations (Molkov et al., 2010, Molkov et al., 2014a). 
Based on this we can assume that NTS peripheral chemoreceptors accelerate phrenic 
discharges by exciting the inspiratory neurons in the pre-BotC which is reflected in the 
model by direct excitatory projections from NTS to the pre-I/I population (Fig. 4). This 
possibility is supported by previous studies showing that microinjections of glutamate in the 
pre-BötC increase PN frequency in vivo and in situ while the antagonism of ionotropic 
glutamatergic receptors in this area eliminated the PN, but not the AbN and tSN responses to 
peripheral chemoreflex activation in situ (Moraes et al., 2011, Moraes et al., 2012c).
Peripheral chemoreceptor activation leads to the emergence of late-E discharges in the 
abdominal and sympathetic nerve activities (Fig. 2). These late-E bursts strongly resemble 
the discharges appearing in the same nerves during hypercapnia (Molkov et al., 2011). 
Appearance of late-E activity during hypercapnia is mediated by the increased tonic drive 
provided by the RTN chemoreceptors (Molkov et al., 2010). Further, late-E discharges 
emerging in AbN and thSN during peripheral chemoreceptor stimulation can be abolished 
by pharmacological suppression of the RTN (Moraes et al., 2012a). These facts are 
consistent with the hypothesis that NTS second order peripheral chemoreceptive neurons 
send excitatory inputs to the RTN central chemoreceptors (Takakura et al., 2006) 
(Hypothesis 1). This was implemented in the model as direct excitatory projections from 
2nd order peripheral chemoreceptive NTS neurons to RTN chemoreceptors (Fig. 4).
Activation of peripheral chemoreceptors is accompanied by powerful discharges in HN, 
cVN, AbN, and tSN motor outputs during post-inspiratory phase of the respiratory cycle 
(Fig. 2). This means that activation of 2nd order NTS chemoreceptive cells may have a direct 
excitatory effect on expiratory neurons. Direct excitation of post-I or aug-E neurons in the 
BötC compartment of the respiratory CPG would be inconsistent with an increase in the 
respiratory frequency. Accordingly, we suggest that this post-I activity is recruited at the 
level of pattern formation rather than pattern generation. In the model, we placed a new 
population in the cVRG which is silent at baseline conditions. It receives inhibition from 
early-I and aug-E populations and excitation from NTS chemoreceptive neurons (Fig. 2). 
During peripheral chemoreceptor activation, the latter evokes post-I activity in the neurons 
of this population in the cVRG as they are inhibited in all other phases of the respiratory 
cycle. The cVRG post-I population sends excitatory inputs to hypoglossal, vagal, abdominal 
and sympathetic nerves thus providing post-I discharges during peripheral chemoreceptor 
stimulation (Figs. 2, 5, 6).
There is well-documented evidence of direct excitatory projections from 2nd order NTS 
peripheral chemoreceptive neurons to the RVLM (see Accorsi-Mendonca and Machado 
(2013) for review) which mediate sympathoexcitatory effect of peripheral chemoreceptor 
stimulation. Our model implies that there are at least two more indirect pathways mediated 
by the respiratory neurons (Hypothesis 2).
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The first is a consequence of excitatory projections from RTN late-E population to RVLM 
suggested in our previous publications (Baekey et al., 2010, Molkov et al., 2011, Rybak et 
al., 2012, Molkov et al., 2014b) to explain appearance of late-E discharges in the 
sympathetic activity during hypercapnia. The RTN late-E population receives excitatory 
drive from the RTN central chemoreceptors which increases with blood CO2 level due to 
their intrinsic CO2 chemosensitivity. Our model suggests that an excitatory input from the 
NTS peripheral chemoreceptors to RTN central chemoreceptors (Takakura et al., 2006), is 
functionally important to activate RTN late-E neurons and to consequently evoke late-E 
discharges in the sympathetic nerve during peripheral chemoreceptor stimulation. The 
critical role of the RTN in the generation of late-E bursts during peripheral chemoreflex was 
previously demonstrated (Moraes et al., 2012a).
The second indirect pathway is mediated by the post-I population, which we introduced to 
explain the occurrence of strong post-inspiratory discharges in multiple respiratory and 
sympathetic motor outputs, and putatively placed to the cVRG compartment of the 
respiratory network. This new population receives inhibition during inspiratory and E2 
phases, and can only activate during post-inspiration by an excitatory peripheral 
chemoreceptor drive from NTS. Apparently, this post-I mediated pathway seems to play a 
dominant role, since the depression of post-inspiratory activity elicited either by the 
glutamatergic antagonism in the NTS (Costa-Silva et al., 2010) or pontine-medullary 
transection (Baekey et al., 2008) significantly attenuated the sympatho-excitatory response 
to peripheral chemoreflex stimulation.
CIH-induced central and peripheral plasticity
Given that the pre-I/I population of the pre-BötC is a primary target for tonic excitatory 
drives to the respiratory CPG and that these drives are strongly activated during the 
peripheral chemoreflex response (Moraes et al., 2014), we speculate that repetitive activation 
of the peripheral chemoreflex may induce plasticity of channel expression due to prolonged 
excessive excitation. Recent evidence in SHR indicates a decrease in the leak conductance of 
pre-inspiratory neurons in the pre-Bötzinger complex (Moraes et al., 2014) which elevates 
their excitability. Our model shows that similar changes as a result of CIH exposure may 
explain abovementioned downshifts in the CO2 thresholds (Hypothesis 3). However, the 
mechanisms responsible for such plasticity remain to be found.
One possibility is that this change is mediated downregulation of potassium leak channels. 
Persistent and repetitive activation of group I metabotrobic glutamate receptors over the 
course of CIH conditioning would increase the catalyzation of diacylglycerol, leading to 
activation of protein kinase C and the subsequent decrease of the leak conductance through 
channel protein trafficking (Gabriel et al., 2012). Another example of similar changes 
consistent with the timescale considered in our study is an excitotoxicity-mediated 
transcriptional decrease in HCN channel function found to increase excitability of CA1 cells 
(Adams et al., 2009). In that study an induced increase in synchronous burst duration 
correlated with a reduction in HCN2 mRNA levels which persisted for at least 7 days. HCN 
channels are primarily permeable to K+ ions, and, hence, their downregulation positively 
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affects the excitability. This is consistent with the recent idea of peripheral chemoreceptor 
mediated channelopathy within the respiratory network in SHRs (Moraes et al., 2015).
As already mentioned, after CIH conditioning the respiratory CPG exhibits higher 
respiratory rate and lower CO2 thresholds for both late-E activity emergence and hypocapnic 
apnea (Figs. 1, 9). Previously this was explained by increased CO2 sensitivity of the RTN 
central chemoreceptors following CIH exposure (Molkov et al., 2011) but no experimental 
evidence of any intrinsic changes in the central chemoreceptors is available. Our present 
model provides a different explanation based on increased excitability of the pre-BötC pre-
I/I population discussed above. Since this population is a main driver of the inspiratory 
activity in the network, its increased excitability alone would lead to lesser dependence on 
excitatory drive from RTN central chemoreceptors and, hence, to a lower apneic threshold. 
To explain the lower threshold for late-E emergence we hypothesize and implement in the 
model that pre-I/I neurons send excitatory projections to the RTN late-E population (Fig. 4). 
Due to increased excitability after CIH exposure, pre-I/I neurons increase their firing 
including the pre-I (late-E) phase and thus provide additional excitation to the RTN late-E 
population which underlies the emergence of late-E activity at lower CO2 levels (Fig. 9).
CIH conditioned rats exhibit a stronger peripheral chemoreflex evoked sympathetic response 
than control animals (Fig. 3). We speculate that this effect reflects stronger activation of the 
direct sympathoexcitatory pathway rather than indirect inputs from respiratory populations. 
This assumption is in accord with the fact that CIH exposure increases the duration but not 
the magnitude of the respiratory response to PC stimulation (Fig. 3). We suggest that the 
underlying mechanism is chronic sensitization of peripheral chemoreceptors during CIH 
conditioning which finds strong experimental support (Pawar et al., 2008, Tan et al., 2010, 
Zoccal et al., 2011, Costa-Silva et al., 2012, Kumar and Prabhakar, 2012). That is not to say 
that baseline facilitation of motoneuron activity in CIH rats is dependent on peripheral 
chemoreceptor sensitization. For example, AbN and tSN late-E activity persists despite 
carotid body transection after CIH conditioning (Zoccal et al., 2008).
Alternative brainstem plasticity could contribute to increased peripheral chemoreflex 
sympathoexcitation after CIH conditioning. For example glutamatergic transmission in the 
NTS is augmented in CIH (Costa-Silva et al., 2012). In this case, plasticity of NTS 
chemoreceptive neural response to peripheral chemoreflex stimulation could amplify the 
motoneuron responses independent of the strength of the input from the carotid body. 
Besides, CIH conditioning increases the strength of the purinergic sympathoexcitatory 
response in the RVLM (Zoccal et al., 2011). This mechanism could account for increased 
sympathoexcitatory response to peripheral chemoreflex stimulation. In the model we 
implement that as a greater activity of the 2nd-order chemoreceptive NTS neurons in CIH-
conditioned animals as compared to the naïve ones. Our simulations support the plausibility 
of this assumption (Fig. 8).
Conclusions
The generation of novel bursts in sympathetic activity coupled with the emergence of active 
expiration has been highlighted as an important mechanism underpinning high levels of 
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sympathetic activity and arterial pressure in rats submitted to CIH (Zoccal et al., 2008, 
Zoccal et al., 2009, Moraes et al., 2013). Although carotid body chemoreceptors were found 
to be critical for the development of CIH-induced arterial hypertension (Fletcher et al., 
1992), inputs from peripheral chemoreceptors are not required for the maintenance of 
expiratory component of the sympathetic activity – since the carotid body removal after CIH 
exposure did not eliminate late-E activity in the sympathetic nerve (Molkov et al., 2011). In 
fact, hypocapnia-induced reduction of respiratory drive canceled the sympathetic and 
abdominal late-E bursts in CIH rats and rescued the normal sympathetic burst pattern 
(Molkov et al., 2011), indicating that coupling between respiratory and sympathetic 
networks is a critical mechanisms for maintenance of sympathetic overactivity after CIH 
exposure. In our study, we sought to identify the potential neural mechanisms required for 
the development of active expiration and sympathetic overactivity in CIH rats.
In order to simulate motoneuron activity of rats conditioned by CIH, a subset of parameters 
in the CIH model were altered from the values in the control model. These changes reflected 
central and peripheral plasticity. We modeled central plasticity in the brainstem by 
increasing the excitability of the pre-I/I population. The conductance of the leak current in 
neurons of the pre-I/I population was changed from 2.9 nS to 2.3 nS. This change mediated 
the hypocapnic shift in apneic threshold and the threshold for the emergence of active 
expiration (Fig. 9). We mimicked peripheral plasticity due to CIH by increasing the 
excitatory drive to 2nd-order chemoreceptive neurons in the NTS during peripheral 
chemoreflex. In the control model, the weight of this drive was 0.75 nS, and it increased in 
magnitude to 1.6 nS in the CIH model. The effect of this change is only visible during 
stimulation of the peripheral chemoreflex (Fig. 8).
Our hypothesis implies that the discussed plastic changes in the respiratory network 
critically depend on the peripheral chemoreceptor input and not on hypoxia per se. This is 
indirectly supported by multiple experimental studies (see (Paton et al., 2013a) for review) 
and emphasizes the importance of carotid bodies as a possible therapeutic target for treating 
neurogenic hypertension (Paton et al., 2013b).
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Figure 1. 
Recordings depict activity of PN and AbN under progressive hypocapnia and hypercapnia in 
in situ preparations of control and CIH rats. The hypercapnic threshold for emergence of 
late-expiratory activity in AbN decreases after CIH. The hypocapnic threshold for the 
appearance of respiratory activity in PN is also decreased in CIH rats. Adapted from 
(Molkov et al., 2011).
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Figure 2. 
Appearance of additional motoneuron activation during peripheral chemoreceptor activation. 
Tracings from two recordings from in situ preparations (panels A and B), representative 
from the group, showing the changes in the HN, cVN, PN, AbN and tSN in response to 
peripheral chemoreceptor activation by KCN (arrows, 0.05%). Note that during chemoreflex 
activation, post inspiratory activity increases in cVN and novel post-inspiratory components 
appears in tSN, AbN, and HN. Late expiratory activity also appears in SN, AbN, and HN. 
Gray bars highlight post-inspiratory phases of the respiratory cycle.
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Figure 3. 
Tracings from control (left) and CIH (right) rats, representative from their respective 
experimental group, showing the PN, AbN and tSN responses to stimulation of the 
peripheral chemoreflex with KCN (arrows). Note the amplified tSN response during 
peripheral chemoreceptor stimulation in CIH rats.
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Figure 4. 
Network connectivity diagram for model of brainstem respiratory circuits. Brainstem 
compartments: VRC, ventral respiratory column; BötC, Bötzinger complex; pre-Bötzinger 
complex; rVRG, rostral ventral respiratory group; cVRG, caudal ventral respiratory group; 
NTS, nucleus tractus solitarii; RTN/pFRG retrotrapezoid nucleus/parafacial respiratory 
group; RVLM, rostral ventrolateral medulla; CVLM, caudal ventrolateral medulla. Neural 
populations: pre-I/I, pre-inspiratory/inspiratory; early-I(1), early inspiratory (1); ramp-I, 
ramp inspiratory; early-I(2), early inspiratory (2); post-I, post inspiratory; post-I (e), post 
inspiratory excitatory; aug-E, augmenting expiratory; 2nd Chemo, 2nd-order 
chemoreceptors; bulbo-spinal post-I, bulbo-spinal post inspiratory; late-E, late expiratory; 
IE, inspiratory-expiratory phase-spanning; RTN-CPG, CO2-sensitive population projecting 
to CPG and late-E (pFRG); RTN-late-E, CO2-sensitive population projecting just to late-E 
(pFRG). Motoneurones: PN, phrenic nerve; AbN, abdominal nerve; tSN, thoracic 
sympathetic nerve; HN, hypoglossal nerve; cVN, cervical vagus nerve. Excitatory neural 
populations, inhibitory neural populations, and excitatory drives are respectively represented 
as orange spheres, blue spheres, and green triangles. Motoneurones are depicted as brown 
spheres. Orange projections originating in neural populations depict excitatory projections. 
Blue projections originating in neural populations depict inhibitory projections. Green 
projections indicate the distribution of excitatory tonic drive.
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Figure 5. 
Simulation depicting the response of motoneuron output (HN, cVN, PN, AbN, and tSN) to 
the activation of the peripheral chemoreflex (A) and the motoneuron response during 
suppression of RTN (B). (A) During activation of peripheral chemoreflex, network 
frequency increases; post-inspiratory activity appears in HN, AbN, and tSN motor nerves, 
and post-inspiratory activity in cVN increases in amplitude. Late expiratory activity appears 
in HN, AbN, and tSN. (B) The suppression of the RTN abolishes late-expiratory activity in 
HN, AbN, and tSN but has little effect on post-I activity. The interval highlighted in yellow 
corresponds to the duration over which the peripheral chemoreflex is stimulated. Baseline 
activity of PN is highlighted in grey to emphasize the difference in frequency in the control 
model and the model with RTN suppressed before the peripheral chemoreflex stimulation.
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Figure 6. 
Simulation of activity of respiratory and sympathetic populations (early-I (1) (pre-BötC), 
post-I (BötC), aug-E (BötC), late-E (pFRG), and post-I (cVRG)) before and during 
stimulation of peripheral chemoreflex (A) and the activity of respiratory and sympathetic 
populations under suppression of RTN during stimulation of peripheral chemoreflex (B). (A) 
Peripheral chemoreflex increases drive to the respiratory central pattern generator—
increases network frequency and activating the late-E (pFRG) and post-I(cVRG) 
populations. (B) The suppression of RTN for the duration of the simulation abolishes 
expiratory activity in the late-E (pFRG) population.
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Figure 7. 
Blow-up of activity during peripheral chemoreflex in the control model. Motoneuron output 
is compared to the activity of late-E (pFRG) and post-I (cVRG). Activity during late-E and 
post-I phases are highlighted in yellow and grey, respectively.
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Figure 8. 
Simulations of (A) the control model and (B) the CIH model depicting activity in PN and 
tSN. The amplitude of tSN activity is increased in the CIH model compared to the control 
model with late-E bursting present.
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Figure 9. 
Simulations of progressive (A) hypercapnia and (B) hypocapnia in PN and AbN in the 
control model and the CIH model. (A) Simulations reproduce hypocapnic shift in threshold 
for the emergence of late-expiratory activity in the AbN in the CIH model. (B) Simulations 
reproduce hypocapnic shift in the onset of respiratory activity of the PN in the CIH model.
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Table 1
Weights of synaptic connections in the network.
Target
Population
Excitatory Drive [weight of synaptic input] or
Presynaptic Source Population [weight of synaptic
input from single neuron]
IE(pons)
RTN-late-E†
RTN-cpg†
RVLM
ramp-I (rVRG) [0.025]*
Drive CO2 [1.08]#
Drive CO2 [1.08]#, 2nd Chemo (NTS) [0.1]#
CVLM [−0.0125]*, Drive (VLM) [0.3]*, IE (pons)
[0.3]*, early-I (2) (rVRG) [−0.01], late-E (pFRG)
[0.03], 2nd Chemo (NTS) [0.01]#, post-I (BotC) [−
0.01]*, post-I (cVRG) [0.15]#
aug-E (BotC) Drive (pons) [2.7], early-I (1) (pre-BotC) [−0.135],
post-I (BotC) [−0.3]
early-I (1)
(pre-BotC) Drive (pons) [1.1]
*
, RTN-cpg [1], aug-E (BotC) [−
0.265]*, 2nd Chemo (NTS) [0.05]# ,post-I (BotC) [−
0.45], pre-I/I (pre-BotC) [0.1]
early-I (2)
(rVRG)
late-E (pFRG)
Drive (pons) [2.5], aug-E (BotC) [−0.25], late-E
(pFRG)[0.1], post-I (BotC) [−0.5]
RTN-late-E [0.18]#, RTN-cpg [0.12]#, early-I (1)
(pre-BotC) [−0.0425]*, late-E (pFRG) [0.024]*, post-
I (BotC) [−0.03]*, pre-I/I (pre-BotC) [0.015]#
2nd Chemo
(NTS)†
Peripheral Chemoreflex Stimulation [0.75a/1.6b]#
post-I (BotC) Drive (pons) [1.65]*, RTN-cpg [0.05]#, aug-E
(BotC) [−0.01]*, early-I (1) (pre-BotC) [−0.025],
post-I (cVRG)† aug-E (BotC) [−0.03]#, early-I (1) (pre-BotC) [−
0.05]#, 2nd Chemo [0.0375]#
post-I (e)
(BotC) Drive (pons) [1]
*
, aug-E (BotC) [−0.2]*, early-I (2)
(rVRG) [−0.01]*
pre-I/I (pre-
BotC) Drive (pons) [0.7]
*
, Drive (raphe) [0.3], RTN-cpg
[0.11]*, aug-E (BotC) [−0.06], late-E (pFRG)
[0.018]*, 2nd Chemo (NTS) [0.02]#, post-I (BotC)
[0.16], pre-I/I (pre-BotC) [0.03]
ramp-I (rVRG) Drive (pons) [2], aug-E (BotC) [−0.1], early-I (2)
(rVRG) [−0.3], post-I (BotC) [−2], pre-I/I (pre-BotC)
[0.12]
*
weights that differ in value from (Molkov et al., 2011).
#projections that did not exist in (Molkov et al., 2011).
†
new populations that did not exist in (Molkov et al., 2011) or (Molkov et al., 2010).
a
chemosensory drive for control simulations during peripheral chemoreflex.
b
chemosensory drive for CIH simulations during peripheral chemoreflex.
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